Charles Ryhee
Stock Analyst at TD Cowen
(1.86)
# 2,556
Out of 4,935 analysts
25
Total ratings
47.62%
Success rate
0.53%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $65.54 | +22.06% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.94 | +17.25% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $668.58 | -2.48% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $155.01 | +9.67% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $9.00 | +555.56% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $157.41 | -54.26% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $0.37 | +216,477.54% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $6.96 | +2,601.15% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $15.46 | +87.58% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $65.54
Upside: +22.06%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.94
Upside: +17.25%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $668.58
Upside: -2.48%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $155.01
Upside: +9.67%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $9.00
Upside: +555.56%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $157.41
Upside: -54.26%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $0.37
Upside: +216,477.54%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $6.96
Upside: +2,601.15%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $15.46
Upside: +87.58%